Cargando…
Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19
Autores principales: | Bowles, Louise, Platton, Sean, Yartey, Nada, Dave, Minal, Lee, Kurtis, Hart, Daniel P., MacDonald, Vickie, Green, Laura, Sivapalaratnam, Suthesh, Pasi, K. John, MacCallum, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Massachusetts Medical Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217555/ https://www.ncbi.nlm.nih.gov/pubmed/32369280 http://dx.doi.org/10.1056/NEJMc2013656 |
Ejemplares similares
-
Automated measurement of coagulation and fibrinolytic activation markers: Outcomes in coronavirus disease 2019 (COVID‐19) patients
por: Gardiner, Chris, et al.
Publicado: (2022) -
Effect on haemostasis of different replacement fluids during therapeutic plasma exchange—A comparative multicentre observational study
por: Kohli, Ruchika, et al.
Publicado: (2022) -
Renal transplant and hemostasis: early postoperative changes in recipients and donors
por: Kohli, Ruchika, et al.
Publicado: (2023) -
Evaluating the Use of a Negative D-Dimer and Modified Low Wells Score in Excluding above Knee Deep Venous Thrombosis in an Outpatient Population, Assessing Need for Diagnostic Ultrasound
por: Rahiminejad, Maryam, et al.
Publicado: (2014) -
Coagulation and anticoagulation in idiopathic pulmonary fibrosis
por: Crooks, Michael G., et al.
Publicado: (2015)